We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$140M
AUM Growth
+$3.27M
Cap. Flow
-$2.65M
Cap. Flow %
-1.9%
Top 10 Hldgs %
21.51%
Holding
171
New
17
Increased
40
Reduced
67
Closed
19

Top Sells

Rank Stock Value
1
AVT icon
Avnet
AVT
+$1.21M
2
ALK icon
Alaska Air
ALK
+$1.03M
3
VRSK icon
Verisk Analytics
VRSK
+$973K
4
PNR icon
Pentair
PNR
+$879K
5
MXL icon
MaxLinear
MXL
+$829K

Sector Composition

Rank Sector Weight
1 Industrials 22.29%
2 Financials 20.68%
3 Healthcare 15.02%
4 Consumer Staples 11.52%
5 Technology 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSU
26
DELISTED
Kansas City Southern
KSU
$1.47M 1.05%
13,980
+11,300
+422% +$1.21M
ZTS icon
27
Zoetis
ZTS
$31.9B
$1.46M 1.05%
20,323
-10,095
-33% -$693K
UPS icon
28
United Parcel Service
UPS
$92.7B
$1.45M 1.04%
12,175
-300
-2% -$35.3K
URI icon
29
United Rentals
URI
$71.6B
$1.45M 1.03%
8,406
-314
-4% -$47.8K
GE icon
30
GE Aerospace
GE
$392B
$1.44M 1.03%
17,171
-2,690
-14% -$257K
PG icon
31
Procter & Gamble
PG
$345B
$1.43M 1.02%
15,521
+5,175
+50% +$465K
CSX icon
32
CSX Corp
CSX
$94.5B
$1.39M 1%
75,969
+2,550
+3% +$45.2K
BMY icon
33
Bristol-Myers Squibb
BMY
$135B
$1.39M 0.99%
22,667
-1,950
-8% -$122K
PYPL icon
34
PayPal
PYPL
$50.1B
$1.35M 0.97%
18,371
-800
-4% -$57.8K
GILD icon
35
Gilead Sciences
GILD
$168B
$1.34M 0.96%
18,705
+215
+1% +$16.3K
DY icon
36
Dycom Industries
DY
$12.5B
$1.33M 0.95%
11,975
-2,934
-20% -$283K
CXT icon
37
Crane NXT
CXT
$3.15B
$1.32M 0.94%
42,609
-2,879
-6% -$84.1K
CELG
38
DELISTED
Celgene Corp
CELG
$1.32M 0.94%
12,626
+1,792
+17% +$202K
ABT icon
39
Abbott
ABT
$183B
$1.3M 0.93%
22,827
-675
-3% -$37.4K
PGEM
40
DELISTED
Ply Gem Holdings, Inc.
PGEM
$1.27M 0.91%
68,531
-7,198
-10% -$125K
NKE icon
41
Nike
NKE
$61.6B
$1.26M 0.9%
20,110
-925
-4% -$53.2K
MDT icon
42
Medtronic
MDT
$110B
$1.25M 0.9%
15,528
-1,654
-10% -$132K
EMR icon
43
Emerson Electric
EMR
$88.9B
$1.25M 0.89%
17,870
-750
-4% -$48.6K
RTX icon
44
RTX Corp
RTX
$294B
$1.24M 0.89%
15,490
+3,814
+33% +$290K
EXPD icon
45
Expeditors International
EXPD
$23.7B
$1.24M 0.88%
19,100
-1,200
-6% -$73.5K
APD icon
46
Air Products & Chemicals
APD
$65.6B
$1.17M 0.84%
7,150
-175
-2% -$27.9K
BRK.B icon
47
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.14M 0.82%
5,750
MDC
48
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.1M 0.79%
+40,159
New +$1.11M
LPX icon
49
Louisiana-Pacific
LPX
$5.36B
$1.09M 0.78%
41,620
+6,700
+19% +$182K
SBUX icon
50
Starbucks
SBUX
$120B
$1.06M 0.76%
18,500
+12,900
+230% +$730K

Similar funds

New England Research & Management's Q4 2017 Portfolio in Review

As of Q4 2017, New England Research & Management held 171 positions worth $140M, up 2.4% from $136M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q4 2017 filing shows 17 new, 40 increased, 67 reduced and 19 closed positions. Its largest new stake was M.D.C. Holdings, Inc.: 40,159 shares worth $1.1M. The largest sale was Avnet, an estimated $1.21M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • New England Research & Management's largest Q4 2017 buy was M.D.C. Holdings, Inc.: 40,159 shares worth $1.1M.
  • New England Research & Management added most to Kansas City Southern in Q4 2017, an estimated $1.21M increase.
  • New England Research & Management's biggest Q4 2017 reduction was Alaska Air, cutting an estimated $1.03M.
  • New England Research & Management fully exited Avnet in Q4 2017, selling an estimated $1.21M.
  • New England Research & Management's ten largest holdings make up 22% of its $140M portfolio in Q4 2017.
  • New England Research & Management opened 17 new positions and closed 19 in Q4 2017.
  • New England Research & Management's portfolio value rose 2.4% quarter-over-quarter to $140M.

Based on New England Research & Management's 13F filing for Q4 2017, filed 9 Jan 2018.